Cosmo Pharmaceuticals NV (COPN) – Medical Equipment – Deals and Alliances Profile

Cosmo Pharmaceuticals NV (COPN) – Medical Equipment – Deals and Alliances Profile

News5050 – Company Reports

December 21, 2017

The Report:

Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company that develops drugs for the treatment of gastro-intestinal diseases. The company develops its pharmaceutical products based on its multi matrix (MMX) technology. Its proprietary clinical development pipeline intended for the treatment of various gastro-intestinal tract, inflammatory bowel diseases, colon infections and colon diagnosis. Cosmo also offers SIC 8000, a submucosal injectable composition for extracting polyps and adenomas; and other products. The company manufactures products for oral administration such as tablets, capsules, powders and syrups; topical dosage forms such as emulsions, gels, ointments and others; and injectables. Its manufacturing facility is located in Lainate, Milan. Cosmo is headquartered in Dublin, Ireland.

Scope

– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
– Business Description – A brief description of the company’s operations.
– Key Employees – A list of the key executives of the company.
– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
– Key Competitors – A list of the key competitors of the company.
– Key Recent Developments – A brief on recent news about the company.

About Research and Experts:

Research and Experts brings you to the latest reports in market research on Medical Devices and much more.

Contact:

John Caldwell

Fia Rua, Deerpark

Bunratty, Co. Clare, Ireland

Check out Market Reports at www.researchandexperts.com

News5050 - ResearchandExperts


Report: REP000345175

Avalign Technologies Inc – Medical Equipment – Deals and Alliances Profile

Avalign Technologies Inc – Medical Equipment – Deals and Alliances Profile

News5050 – Company Reports

December 21, 2017

The Report:

Avalign Technologies Inc (Avalign), a subsidiary of Arlington Capital Partners LP is a medical device company that offers cutting instruments. The company offers cutting instruments, cases and trays, german instruments and instruments and implant products. It manufactures instruments and implants through CNC mills, citizen swiss turning centers, mill turns, wire EDMs, gun drills, coordinate measuring machines, OGP vision measurement system and ultrasonic cleaning technologies. The company also offers research and development; design, prototyping, testing and production programs. It operates in Lake Forest, Warsaw, Greenwood, Fort Wayne, Schaumburg and Tuttlingen. Avalign is headquartered in Lake Forest, Illinois, the US.

Scope

– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
– Business Description – A brief description of the company’s operations.
– Key Employees – A list of the key executives of the company.
– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
– Key Competitors – A list of the key competitors of the company.
– Key Recent Developments – A brief on recent news about the company.

About Research and Experts:

Research and Experts brings you to the latest reports in market research on Medical Devices and much more.

Contact:

John Caldwell

Fia Rua, Deerpark

Bunratty, Co. Clare, Ireland

Check out Market Reports at www.researchandexperts.com

News5050 - ResearchandExperts


Report: REP000345174

BioRestorative Therapies Inc (BRTX) – Medical Equipment – Deals and Alliances Profile

BioRestorative Therapies Inc (BRTX) – Medical Equipment – Deals and Alliances Profile

News5050 – Company Reports

December 21, 2017

The Report:

BioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance Inc is a developer of therapeutic products and medical therapies. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is designed to offer a non-surgical treatment for chronic lumbar disc diseases such as bulging and herniated discs. The company’s ThermoStem program develops brown fat stem cell-based therapy which is used for the treatment of type 2 diabetes, obesity, and other metabolic disorders. It offers identification and treatment of first stem cell population isolated from a particular brown fat depot in humans. BRT is headquartered in Melville, New York, the US.

Scope

– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
– Business Description – A brief description of the company’s operations.
– Key Employees – A list of the key executives of the company.
– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
– Key Competitors – A list of the key competitors of the company.
– Key Recent Developments – A brief on recent news about the company.

About Research and Experts:

Research and Experts brings you to the latest reports in market research on Medical Devices and much more.

Contact:

John Caldwell

Fia Rua, Deerpark

Bunratty, Co. Clare, Ireland

Check out Market Reports at www.researchandexperts.com

News5050 - ResearchandExperts


Report: REP000345173

Broncus Medical Inc – Medical Equipment – Deals and Alliances Profile

Broncus Medical Inc – Medical Equipment – Deals and Alliances Profile

News5050 – Company Reports

December 21, 2017

The Report:

Broncus Medical Inc (Broncus), formerly Broncus Technologies Inc is a medical device company that develops navigation, diagnostic and therapeutic technologies. The company’s products comprise lungpoint virtual bronchoscopic navigation system, lungpoint satellite planning system, and flexneedle. Its lungpoint virtual bronchoscopic navigation system provides real time navigation within lungs for lung biopsy and other DX and TX procedures. Broncus’s product simultaneously shows the live and virtual views and the path to follow. The company offers therapeutic technologies for the treatment of lung diseases. Its flexneedle provides ability to reach lesions in the peripheral segments of the lung. Broncus is headquartered in San Jose, California, the US.

Scope

– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
– Business Description – A brief description of the company’s operations.
– Key Employees – A list of the key executives of the company.
– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
– Key Competitors – A list of the key competitors of the company.
– Key Recent Developments – A brief on recent news about the company.

About Research and Experts:

Research and Experts brings you to the latest reports in market research on Medical Devices and much more.

Contact:

John Caldwell

Fia Rua, Deerpark

Bunratty, Co. Clare, Ireland

Check out Market Reports at www.researchandexperts.com

News5050 - ResearchandExperts


Report: REP000345172

InvitroCue Ltd (IVQ) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

InvitroCue Ltd (IVQ) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

News5050 – Company Reports

December 21, 2017

The Report:

InvitroCue Ltd (InvitroCue), formerly Bunuru Corporation Ltd is a provider of bio-analytic solutions. The company offers digital pathology services such as digitization, sample preparation, staining, computer aided diagnosis and consultation, telepathology, automated reporting and image archiving, among others. It offers cell-based services to pharmaceutical and cosmetics companies for ingredients, drugs, compounds and vaccine discovery. InvitroCue offers solutions in fields of in vitro drug metabolism and pharmacokinetic, in vitro toxicology and digital pathology. The company also offers image analytics services for liver disease applications. It has operations in Australia, Singapore and China. InvitroCue is headquartered in Sydney, New South Wales, Australia.

Scope

– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
– Business Description – A brief description of the company’s operations.
– Key Employees – A list of the key executives of the company.
– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
– Key Competitors – A list of the key competitors of the company.
– Key Recent Developments – A brief on recent news about the company.

About Research and Experts:

Research and Experts brings you to the latest reports in market research on Life Sciences and much more.

Contact:

John Caldwell

Fia Rua, Deerpark

Bunratty, Co. Clare, Ireland

Check out Market Reports at www.researchandexperts.com

News5050 - ResearchandExperts


Report: REP000345191

National Cancer Centre Singapore – Pharmaceuticals & Healthcare – Deals and Alliances Profile

National Cancer Centre Singapore – Pharmaceuticals & Healthcare – Deals and Alliances Profile

News5050 – Company Reports

December 21, 2017

The Report:

National Cancer Centre Singapore (NCCS) is a healthcare service provider that offers research and cancer treatment services. The center offers research for cancers such as breast, gynaecology, haematology, head and neck, neuro oncology, naso pharynx cancer, paediatrics, reconstructive, hepatobiliary, lymphoma, musculoskeletal and colorectal. It provides genetic counselling, risk evaluation and prevention and geriatric oncology. NCCS medical diagnosis, treatment and care for all cancer patients. The center also offers research facility consists of genetic microarray system, flow cytometry, confocal microscopy, DNA sequencing, animal holding rooms, and others. It also provides training programs for oncologists, researchers, clinician scientists and health professionals. NCCS is headquartered in Singapore.

Scope

– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
– Business Description – A brief description of the company’s operations.
– Key Employees – A list of the key executives of the company.
– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
– Key Competitors – A list of the key competitors of the company.
– Key Recent Developments – A brief on recent news about the company.

About Research and Experts:

Research and Experts brings you to the latest reports in market research on Life Sciences and much more.

Contact:

John Caldwell

Fia Rua, Deerpark

Bunratty, Co. Clare, Ireland

Check out Market Reports at www.researchandexperts.com

News5050 - ResearchandExperts


Report: REP000345190